SCHEMBL4713592

SCHEMBL4713592

CCOC(=O)c1ncn(-c2cccc(C#Cc3cccc(C)n3)c2)n1

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4712463 0.86 GRM5 (0.49) GRM5
SCHEMBL4713871 0.84 GRM5 (0.42) GRM5
SCHEMBL4711597 0.84 GRM5 (0.44) GRM5
SCHEMBL4711486 0.80 GRM5 (0.46) GRM5
SCHEMBL4711268 0.77 GRM5 (0.43) GRM5
SCHEMBL22366278 0.77 HTT (0.54) MAPT
SCHEMBL4710798 0.77 GRM5 (0.54) GRM5
SCHEMBL22319687 0.76 MAPT (0.52) MAPT
SCHEMBL19402109 0.76 MAPT (0.52) MAPT
SCHEMBL4710432 0.70 GRM5 (0.53) GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP claimed
EP-0998459-A2 PYRIDINE DERIVATIVES Novartis AG (CH) 2000-05-10 EP claimed
WO-1999002497-A2 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 1999-01-21 WO claimed
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP disclosed